Therefore, closely monitoring DM should be considered for young-onset CRC patients with larger tumor size, undifferentiated carcinoma, tumor grades of T4 or N2 stage, treatment without radiation or treatment with chemotherapy after surgery, and pretreatment CEA positive. Here, CEACAM5 is linked to undifferentiated carcinoma.